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Abstract 
Background: There is a growing recognition of sex and gender influences in autism. Increasingly, studies include 
comparisons between sexes or genders, but few have focused on clarifying the characteristics of autistic girls’/wom‑
en’s physical health.
Methods: A scoping review was conducted to determine what is currently known about the physical health of autis‑
tic girls/women. We screened 1112 unique articles, with 40 studies meeting the inclusion criteria. We used a conver‑
gent iterative process to synthesize this content into broad thematic areas.
Results: Autistic girls/women experience more overall physical health challenges compared to non‑autistic girls/
women and to autistic boys/men. Emerging evidence suggests increased prevalence of epilepsy in autistic girls/
women compared to non‑autistic girls/women and to autistic boys/men. The literature also suggests increased endo‑
crine and reproductive health conditions in autistic girls/women compared to non‑autistic girls/women. Findings 
regarding gastrointestinal, metabolic, nutritional, and immune‑related conditions are preliminary and inconsistent.
Limitations: The literature has substantial heterogeneity in how physical health conditions were assessed and 
reported. Further, our explicit focus on physical health may have constrained the ability to examine interactions 
between mental and physical health. The widely differing research aims and methodologies make it difficult to reach 
definitive conclusions. Nevertheless, in keeping with the goals of a scoping review, we were able to identify key 
themes to guide future research.
Conclusions: The emerging literature suggests that autistic girls/women have heightened rates of physical health 
challenges compared to non‑autistic girls/women and to autistic boys/men. Clinicians should seek to provide holistic 
care that includes a focus on physical health and develop a women’s health lens when providing clinical care to autis‑
tic girls/women.
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Background
Autism spectrum disorder (hereafter autism) is a neu-
rodevelopmental condition characterized by early-onset 
social communication difficulties and repetitive, ste-
reotyped behaviors. The estimated prevalence rate of 
autism is approximately 1% worldwide [1], with a higher 
prevalence among males than females [2, 3]. The widely 
reported male-to-female ratio for autism prevalence is 
4–5:1 but large-scale, population-based epidemiological 
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studies suggest that the ratio is in fact lower, at 3–4:1 [4]. 
The higher rates of autism among males reflect sex and 
gender differences in the likelihood of developing autism 
and potential gender biases in clinical assessment and 
diagnoses [5, 6].
Autism is highly associated with co-occurring health 
conditions [7]. It is hypothesized that this likely reflects 
complex epigenetic and pleiotropic gene–environment 
interactions and behavioral mechanisms [3, 8], which 
complicate the clinical presentation of autism. Co-occur-
ring health conditions in autism are associated with var-
ied developmental trajectories [9, 10] and unique social 
and psychological challenges experienced throughout the 
life course [3]. In order to improve our knowledge of sex-
based and gender-based differences in autism [11], it is 
critical to better understand the prevalence and charac-
teristics of co-occurring conditions in autistic girls and 
women.
Most research on co-occurring conditions in autistic 
girls/women relative to boys/men has focused on psy-
chiatric conditions, suggesting increased internalizing 
psychopathology in autistic girls/women compared to 
in boys/men [12–14]. The latest meta-analysis on co-
occurring psychiatric diagnoses in autistic people shows 
that studies with a higher proportion of girls/women 
tend to find higher rates of depression [15]. However, 
less attention has been paid to sex and gender differ-
ences in autism outside of the domain of mental health, 
especially regarding physical health. (Note that we define 
physical health in this context to encompass non-mental 
health conditions within the broad category of medical 
disorders or problems.) Accurate and in-depth informa-
tion in this domain, especially concerning autistic girls/
women, is essential to the provision of comprehensive 
and sex- and gender-sensitive health care and is impor-
tant for elucidating clinically useful subgroups within the 
autism spectrum. In view of this, we conducted a scoping 
review of the literature, focused on the extent and range 
of research pertaining to the physical health of autistic 
girls/women. Two research questions guided our review: 
(1) What do we know about the physical health of autis-
tic girls/women; and (2) How specific are these physical 
health concerns to autistic girls/women, as compared to 
autistic boys/men, and to non-autistic girls/women?
Methods
We conducted a scoping review of the literature follow-
ing the methodological framework outlined by Arksey 
and O’Malley [16] and recent Preferred Reporting Items 
for Systematic Reviews and Meta-analyses standards for 
scoping reviews (PRISMA-ScR) [17]. Scoping reviews 
allow a broad survey of the literature in a particular area 
to determine existing themes and areas of inquiry that 
are under-researched. Scoping reviews typically do not 
conduct an assessment of bias in the research nor do they 
appraise or generate effect sizes [16]. We considered a 
scoping review to be the most appropriate approach for 
examining emerging evidence concerning the physical 
health of autistic girls/women since it was unclear what 
specific questions should be posed in this area given the 
limitations of current literature. Therefore, our purposes 
were to summarize the extent and range of research per-
taining to physical health in autistic girls/women and to 
identify evidence gaps. In this way, we surveyed all of 
the literature with respect to physical health in autistic 
girls/women, without restrictions based on study design 
or comparison groups. Furthermore, as this literature 
often—unfortunately—conflates gender and sex, it is 
difficult to tease apart their respective effects. Hence, in 
interpreting the findings, references to “girls/women” 
were assumed to refer to biological, cis-gender females 
and references to “gender” were read very carefully to 
determine whether they referred to biological sex or gen-
der identity.
We systematically searched the following databases 
according to PRISMA standards [18]: CINAHL, PubMed, 
EMBASE, PsycINFO, Scopus, and Web of Science (see 
Additional file 1: Appendix: Search Strategy). As this was 
a scoping review aimed at assessing general themes in the 
published literature rather than analyzing specific types 
of data, grey literature was not included in the searches. 
Autism and co-occurring physical health conditions were 
defined using a combination of keywords and controlled 
vocabulary applicable to each database (see Additional 
file  1: Appendix: Search Strategy). We purposely kept 
the definition of “physical health” as broad as possible, in 
order to gather a wide range of studies and gain a thor-
ough coverage of the published literature with respect 
to non-mental health-related conditions. There was no 
publication type or date restriction at this stage, but the 
search results were limited to human studies and journal 
articles written in English. The final database search was 
performed on December 5, 2019, and references were 
managed using Mendeley (https ://www.mende ley.com/).
A systematic selection process was used to determine 
the final articles included in this review. After duplicates 
were removed, two authors (CK and SB) screened titles 
and abstracts with support from senior authors (M-CL 
and GE), using broad criteria to allow for the inclusion of 
any potentially relevant study for further evaluation. Full-
text articles were evaluated for inclusion by CK and SB. 
The pool of studies identified based on screening titles, 
abstracts, and consultations with senior authors deter-
mined the inclusion and exclusion criteria. At this stage, 
articles were included if they: (1) reported on co-occur-
ring physical health conditions in people with a diagnosis 
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of autism as defined by the DSM-IV, DSM-5, or ICD-10 
criteria, or had direct relevance to the physical health of 
autistic girls/women; (2) included a clearly articulated 
sex-specific or gender-specific description or analysis of 
these conditions; (3) studied biological females only, or if 
the total female autism sample size was ≥ 15 and with at 
least one-eighth (12.5%) of the total autism sample being 
biologically female (to ensure that included studies had a 
sufficient number of girls/women to derive sex-specific 
or gender-specific information); (4) reported original, 
English-language research articles or reviews published 
in peer-reviewed scientific journals; and (5) in the case 
of review articles, used systematic search methods and 
included sex-specific or gender-specific analyses and 
interpretation. Articles were excluded if they were: (1) 
review articles using non-systematic search methodol-
ogy; (2) opinion pieces; (3) editorials; (4) case reports; or 
(5) conference papers. Final decisions on which articles 
to include were made in discussion within the research 
team. Articles were grouped by main topic area and study 
design for organizational clarity. Data were extracted 
as shown in Tables 1 and 2, with relevant findings sum-
marized in the Results section. We used a convergent 
iterative process involving multistage revisions among 
all authors to synthesize included studies into a series 
of themes that broadly summarize key findings in the 
literature.
Results
Search results
We screened a total of 1112 unique citations and 
reviewed the full text of 201 articles, with 40 studies ulti-
mately meeting the inclusion criteria (Fig. 1). The major-
ity of the studies were from North America and Europe/
UK, cross-sectional, and about general prevalence rates 
for health conditions in autistic individuals (Table  1). 
The articles included descriptive studies of autistic girls/
women only, as well as studies of autistic individuals of 
all ages and functional levels that compared autistic girls/
women to autistic boys/men and/or non-autistic girls/
women (Table 2).
Three major themes on the physical health status of 
autistic girls/women emerged from the existing literature: 
(1) Autistic girls/women experience more overall physical 
health conditions than autistic boys/men and non-autis-
tic girls/women; (2) Epilepsy has been most commonly 
researched and seems more common in autistic girls/
women compared to autistic boys/men and non-autistic 
girls/women; and (3) Autistic girls/women may experience 
more menstruation-related complications, endocrine and 
reproductive health conditions compared to non-autistic 
girls/women. Finally, studies that met the inclusion cri-
teria but that did not align with the three major themes 
are described in a fourth section, Miscellaneous Emerging 
Findings. Details of sample characteristics, methodology, 
and statistics are provided in Table 2.
Summary of key themes
Theme 1: Overall Physical Health Status
Thirteen out of the 40 included studies focused on the 
overall physical health status of autistic girls/women 
[19–31], with respect to multiple conditions across body 
systems.
Autistic girls/women compared to autistic boys/men Six 
studies explored the prevalence of various co-occurring 
physical health conditions in autistic girls/women and 
autistic boys/men [19–24]. Two of these six studies 
focused on population-based registry data: one in autis-
tic children and youth (25,063 individuals with autism) 
[19] and the other in autistic adults (6649 with autism) 
[20]. Both reported higher odds for deafness, blindness, 
and physical disability in autistic girls/women compared 
to autistic boys/men [19, 20]. A third study [21], a follow-
up on the same adult cohort in [20], found that autistic 
women in the 25–34 years of age range were more likely 
to report “poor general health” compared to autistic men 
[21]. Two additional studies reported on prevalence of 
physical health conditions as a percentage of their total 
registry-based autism sample [22, 23]. In 4123 autistic 
youth in a clinical registry, most physical health condi-
tions were more common in autistic girls/women than in 
autistic boys/men (e.g., allergy/immunologic conditions, 
Table 1 Overview of included studies (n = 40)
Years of publication Country of origin Study design
2007–2020 North America = 17
Europe and UK = 12
Asia = 5
Middle East = 3
Australia = 3
Africa = 0
South America = 0
Systematic reviews and meta‑analyses = 5
Reviews with systematic search methods = 2
Cross‑sectional studies, with population/registry samples = 20
Cross‑sectional studies, with clinic/community samples = 13
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N
ot
 re
po
rt
ed
A
ut
is
tic
 
bo
ys
/m
en
3 
st
ud
ie
s 
in
cl
ud
ed
 s
ex
‑s
pe
ci
fic
 a
na
ly
se
s, 
w
ith
 in
co
ns
is
te
nt
 fi
nd
in
gs
Ru
be
ns
te
in
 e
t a
l. 
[2
8]
U
SA
Re
vi
ew
 w
ith
 
sy
st
em
at
ic
 s
ea
rc
h 
m
et
ho
ds
Se
x 
di
ffe
re
nc
es
 
in
 c
o‑
oc
cu
rr
in
g 
co
nd
iti
on
s
n 
= 
69
 s
tu
di
es
, w
ith
 
sa
m
pl
es
 ra
ng
in
g 
fro
m
 N
 =
 2
8 
to
 
N
 =
 3
37
,0
00
N
ot
 re
po
rt
ed
N
ot
 re
po
rt
ed
N
ot
 re
po
rt
ed
A
ut
is
tic
 
bo
ys
/m
en
In
su
ffi
ci
en
t r
es
ea
rc
h 
(h
en
ce
 e
vi
de
nc
e)
 to
 
dr
aw
 c
on
cl
us
io
ns
 o
n 
se
x 
di
ffe
re
nc
es
 in
 
m
os
t c
o‑
oc
cu
rr
in
g 
he
al
th
 c
on
di
tio
ns
b.
 A
ut
is
tic
 g
irl
s/
w
om
en
 c
om
pa
re
d 
to
 n
on
‑a
ut
is
tic
 g
irl
s/
w
om
en
Ca
w
th
or
pe
 e
t a
l. 
[2
9]
Ca
na
da
C
ro
ss
‑s
ec
tio
na
l 
re
gi
st
ry
 s
am
pl
e
Pr
ev
al
en
ce
 ra
te
s 
fo
r c
o‑
oc
cu
rr
in
g 
he
al
th
 c
on
di
tio
ns
N
 =
 2
04
0 
au
tis
m
, 
N
 =
 7
61
,4
09
 
ge
ne
ra
l p
op
ul
at
io
n 
co
nt
ro
ls
A
ll 
ag
es
28
.6
%
 (1
45
7 
m
al
es
, 5
83
 
fe
m
al
es
)
N
ot
 re
po
rt
ed
Sa
m
e‑
se
x 
ge
ne
ra
l 
po
pu
la
tio
n 
co
nt
ro
ls
A
ut
is
tic
 g
irl
s/
w
om
en
 h
ad
 in
cr
ea
se
d 
od
ds
 c
om
pa
re
d 
to
 n
on
‑a
ut
is
tic
 g
irl
s/
w
om
en
 fo
r m
os
t p
hy
si
ca
l h
ea
lth
 c
on
di
‑
tio
ns
 (e
nc
om
pa
ss
in
g 
al
m
os
t a
ll 
bo
dy
 
sy
st
em
s)
, s
im
ila
r t
o 
th
at
 in
 a
ut
is
tic
 b
oy
s/
m
en
 c
om
pa
re
d 
to
 n
on
‑a
ut
is
tic
 b
oy
s/
m
en
. S
ex
 d
iff
er
en
tia
l p
at
te
rn
s 
w
er
e 
al
so
 
fo
un
d.
 (i
) C
on
di
tio
ns
 o
nl
y 
el
ev
at
ed
 in
 
au
tis
tic
 g
irl
s/
w
om
en
 in
cl
ud
ed
: b
lo
od
 
an
d 
bl
oo
d‑
fo
rm
in
g 
or
ga
n 
di
so
rd
er
s 
(a
ut
is
tic
 fe
m
al
e 
O
R 
1.
35
 [9
5%
 C
I 1
.1
1–
1.
65
], 
au
tis
tic
 m
al
e 
1.
14
 [0
.9
6–
1.
35
]),
 
an
d 
en
do
cr
in
e,
 n
ut
rit
io
na
l, 
m
et
ab
ol
ic
 
di
se
as
es
, a
nd
 im
m
un
ity
 d
is
or
de
rs
 
(a
ut
is
tic
 fe
m
al
e 
1.
47
 [1
.2
5–
1.
73
], 
au
tis
tic
 
m
al
e 
0.
63
 [0
.5
6–
0.
71
]).
 (i
i) 
Co
nd
iti
on
s 
on
ly
 e
le
va
te
d 
in
 a
ut
is
tic
 b
oy
s/
m
en
 
in
cl
ud
ed
: c
om
pl
ic
at
io
ns
 d
ur
in
g 
m
ot
h‑
er
s’ 
pr
eg
na
nc
y/
ch
ild
bi
rt
h 
(a
ut
is
tic
 m
al
e 
1.
52
 [1
.0
7–
2.
15
], 
au
tis
tic
 fe
m
al
e 
0.
55
 
[0
.4
4–
0.
68
]),
 a
nd
 g
en
ito
ur
in
ar
y 
sy
st
em
 
di
se
as
es
 (a
ut
is
tic
 m
al
e 
1.
2 
[1
.0
8–
1.
33
], 
au
tis
tic
 fe
m
al
e 
0.
99
 [0
.8
1–
1.
20
])
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0]
U
SA
C
ro
ss
‑s
ec
tio
na
l 
re
gi
st
ry
 s
am
pl
e
Pr
ev
al
en
ce
 ra
te
s 
fo
r c
o‑
oc
cu
rr
in
g 
he
al
th
 c
on
di
tio
ns
N
 =
 1
50
7 
au
tis
m
, 
N
 =
 1
5,
07
0 
ge
ne
ra
l 
po
pu
la
tio
n 
m
at
ch
ed
 c
on
tr
ol
s
A
du
lts
 
(m
ea
n 
ag
e 
29
.0
 y
ea
rs
, 
SD
 1
2.
2)
26
.9
%
 (1
10
2 
m
al
es
, 4
05
 
fe
m
al
es
)
19
.2
%
Sa
m
e‑
se
x 
ge
ne
ra
l 
po
pu
la
tio
n 
co
nt
ro
ls
A
ut
is
tic
 w
om
en
 h
ad
 in
cr
ea
se
d 
od
ds
 
co
m
pa
re
d 
to
 n
on
‑a
ut
is
tic
 w
om
en
 
fo
r m
os
t p
hy
si
ca
l h
ea
lth
 c
on
di
tio
ns
 
(e
nc
om
pa
ss
in
g 
al
m
os
t a
ll 
bo
dy
 
sy
st
em
s)
, s
im
ila
r t
o 
th
at
 in
 a
ut
is
tic
 m
en
 
co
m
pa
re
d 
to
 n
on
‑a
ut
is
tic
 m
en
. S
ex
 
di
ffe
re
nt
ia
l p
at
te
rn
s 
w
er
e 
al
so
 fo
un
d.
 
(i)
 C
on
di
tio
ns
 o
nl
y 
el
ev
at
ed
 in
 a
ut
is
tic
 
w
om
en
 in
cl
ud
ed
: s
tr
ok
e 
(a
ut
is
tic
 
fe
m
al
e 
O
R 
4.
97
 [9
9%
 C
I 1
.4
6–
16
.8
6]
, 
au
tis
tic
 m
al
e 
1.
48
 [0
.5
9–
3.
70
]).
 (i
i) 
Co
nd
iti
on
s 
on
ly
 e
le
va
te
d 
in
 a
ut
is
tic
 
m
en
 in
cl
ud
ed
: a
ut
oi
m
m
un
e 
di
se
as
es
 
(a
ut
is
tic
 m
al
e 
1.
30
 [1
.0
1–
1.
68
)],
 a
ut
is
tic
 
fe
m
al
e 
1.
12
 [0
.7
8–
1.
60
]) 
an
d 
ga
st
ro
‑
in
te
st
in
al
 d
is
or
de
rs
 (a
ut
is
tic
 m
al
e 
1.
50
 [1
.2
5–
1.
79
], 
au
tis
tic
 fe
m
al
e 
1.
05
 
[0
.8
0–
1.
39
])
H
an
d 
et
 a
l. 
[3
1]
U
SA
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ec
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na
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gi
st
ry
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pl
e
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ev
al
en
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 ra
te
s 
fo
r c
o‑
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cu
rr
in
g 
he
al
th
 c
on
di
tio
ns
N
 =
 4
68
5 
au
tis
m
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N
 =
 4
6,
85
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m
at
ch
ed
 c
on
tr
ol
s
65
 y
ea
rs
 a
nd
 
ol
de
r
32
.2
%
 (3
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5 
m
al
es
, 1
51
0 
fe
m
al
es
)
43
.8
%
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m
e‑
se
x 
ge
ne
ra
l 
po
pu
la
tio
n 
co
nt
ro
ls
A
ut
is
tic
 w
om
en
 h
ad
 in
cr
ea
se
d 
od
ds
 
co
m
pa
re
d 
to
 n
on
‑a
ut
is
tic
 w
om
en
 
fo
r m
os
t p
hy
si
ca
l h
ea
lth
 c
on
di
tio
ns
 
(e
nc
om
pa
ss
in
g 
al
m
os
t a
ll 
bo
dy
 
sy
st
em
s)
, s
im
ila
r t
o 
th
at
 in
 a
ut
is
tic
 m
en
 
co
m
pa
re
d 
to
 n
on
‑a
ut
is
tic
 m
en
. N
o 
se
x 
di
ffe
re
nt
ia
l p
at
te
rn
s 
w
er
e 
fo
un
d.
 T
he
 
th
re
e 
ph
ys
ic
al
 h
ea
lth
 c
on
di
tio
ns
 w
ith
 
th
e 
la
rg
es
t O
Rs
 in
 a
ut
is
tic
 w
om
en
 w
er
e 
ep
ile
ps
y 
(O
R 
20
.8
 [9
5%
 C
I 1
7.
7–
24
.4
]),
 
Pa
rk
in
so
n’
s 
di
se
as
e 
(8
.2
 [6
.2
–1
0.
7]
), 
an
d 
ot
he
r g
as
tr
oi
nt
es
tin
al
 c
on
di
tio
ns
 (4
.6
 
[4
.1
–5
.1
])
Th
em
e 
2:
 E
pi
le
ps
y 
an
d 
Re
la
te
d 
N
eu
ro
lo
gi
ca
l C
on
di
tio
ns
a.
 A
ut
is
tic
 g
irl
s/
w
om
en
 c
om
pa
re
d 
to
 a
ut
is
tic
 b
oy
s/
m
en
St
ac
y 
et
 a
l. 
[3
2]
U
SA
C
ro
ss
‑s
ec
tio
na
l 
re
gi
st
ry
 s
am
pl
e
Pr
ev
al
en
ce
 ra
te
s: 
in
cl
ud
in
g 
ep
ile
ps
y
N
 =
 9
13
 a
ut
is
m
W
ei
gh
te
d 
m
ea
n 
ag
e 
9.
91
 y
ea
rs
 
(fe
m
al
es
 
10
.8
2 
(S
D
 
0.
61
) v
s. 
m
al
es
 9
.7
1 
(S
D
 0
.2
7)
)
18
.3
%
 (7
46
 
m
al
es
, 1
67
 
fe
m
al
es
)
N
ot
 re
po
rt
ed
A
ut
is
tic
 
bo
ys
/m
en
N
o 
si
gn
ifi
ca
nt
 d
iff
er
en
ce
s 
be
tw
ee
n 
au
tis
‑
tic
 g
irl
s/
w
om
en
 a
nd
 a
ut
is
tic
 b
oy
s/
m
en
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3]
Fr
an
ce
Sy
st
em
at
ic
 re
vi
ew
 
an
d 
m
et
a‑
an
al
ys
is
Pr
ev
al
en
ce
 ra
te
s: 
po
ol
ed
 ri
sk
 ra
tio
 
fo
r e
pi
le
ps
y,
 a
nd
 
as
so
ci
at
io
ns
 
w
ith
 ID
N
 =
 1
53
0 
au
tis
m
 in
 
se
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ge
nd
er
 a
na
ly
‑
se
s 
fro
m
 1
4 
st
ud
ie
s
A
ll 
ag
es
22
.2
%
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 s
ex
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ge
nd
er
 
an
al
ys
es
 (1
19
1 
m
al
es
, 3
39
 
fe
m
al
es
)
N
ot
 re
po
rt
ed
A
ut
is
tic
 
bo
ys
/m
en
Lo
w
er
 ri
sk
 fo
r e
pi
le
ps
y 
in
 a
ut
is
tic
 b
oy
s/
m
en
 c
om
pa
re
d 
to
 a
ut
is
tic
 g
irl
s/
w
om
en
 
(R
R 
0.
55
 [9
5%
 C
I 0
.4
5–
0.
66
], 
p 
<
 0
.0
01
; 
34
.5
%
 in
 a
ut
is
tic
 g
irl
s/
w
om
en
 v
s. 
18
.5
%
 
in
 a
ut
is
tic
 b
oy
s/
m
en
)
Ew
en
 e
t a
l. 
[3
4]
U
SA
C
ro
ss
‑s
ec
tio
na
l 
re
gi
st
ry
 s
am
pl
e
Pr
ev
al
en
ce
 ra
te
s: 
ep
ile
ps
y
N
 =
 6
97
5 
au
tis
m
6 
to
 1
8 
ye
ar
s
18
.7
%
 (5
67
1 
m
al
es
, 1
30
4 
fe
m
al
es
)
20
.8
%
A
ut
is
tic
 b
oy
s
H
ig
he
r r
is
k 
fo
r e
pi
le
ps
y 
in
 a
ut
is
tic
 g
irl
s 
co
m
pa
re
d 
to
 a
ut
is
tic
 b
oy
s 
in
 a
 la
rg
er
 
su
b‑
co
ho
rt
 (R
R 
1.
32
 [9
5%
 C
I 1
.1
4–
1.
52
], 
p 
<
 0
.0
5)
 b
ut
 n
o 
si
gn
ifi
ca
nt
 fi
nd
in
gs
 
in
 a
 s
m
al
le
r s
ub
‑c
oh
or
t. 
In
de
pe
nd
en
t 
po
si
tiv
e 
as
so
ci
at
io
ns
 b
et
w
ee
n 
ep
ile
ps
y 
an
d 
in
te
lle
ct
ua
l d
is
ab
ili
ty
, l
an
gu
ag
e 
im
pa
irm
en
t, 
co
re
 a
ut
is
m
 s
ym
pt
om
, a
nd
 
m
ot
or
 d
ys
fu
nc
tio
n
Vi
sc
id
i e
t a
l. 
[3
5]
U
SA
C
ro
ss
‑s
ec
tio
na
l 
re
gi
st
ry
 s
am
pl
e
Pr
ev
al
en
ce
 ra
te
s: 
ep
ile
ps
y
N
 =
 5
81
5 
au
tis
m
A
ll 
ag
es
, 
m
aj
or
ity
 
be
tw
ee
n 
4 
an
d 
12
 y
ea
rs
 
(~
 7
5%
)
17
.5
%
 (4
80
0 
m
al
es
, 1
01
5 
fe
m
al
es
)
N
 =
 4
89
4 
w
ith
 
da
ta
, 1
5.
5%
A
ut
is
tic
 
bo
ys
/m
en
Ep
ile
ps
y 
w
as
 m
or
e 
pr
ev
al
en
t i
n 
au
tis
tic
 
gi
rls
/w
om
en
 (7
.0
%
) t
ha
n 
in
 a
ut
is
tic
 
bo
ys
/m
en
 (3
.9
%
, p
 <
 0
.0
01
). 
Co
‑o
cc
ur
‑
rin
g 
ep
ile
ps
y 
in
 a
ut
is
m
 w
as
 a
ss
oc
ia
te
d 
w
ith
 o
ld
er
 a
ge
, l
ow
er
 c
og
ni
tiv
e 
ab
ili
ty
, 
po
or
 a
da
pt
iv
e 
la
ng
ua
ge
 fu
nc
tio
ni
ng
, 
de
ve
lo
pm
en
ta
l r
eg
re
ss
io
n,
 a
nd
 m
or
e 
se
ve
re
 a
ut
is
m
 s
ym
pt
om
s; 
m
os
t o
f t
he
 
as
so
ci
at
io
ns
 w
er
e 
dr
iv
en
 b
y 
IQ
Bo
w
er
s 
et
 a
l. 
[3
6]
U
SA
C
ro
ss
‑s
ec
tio
na
l 
cl
in
ic
/c
om
m
un
ity
 
sa
m
pl
e
Pr
ev
al
en
ce
 ra
te
s: 
ep
ile
ps
y,
 in
 
pr
et
er
m
 v
s. 
te
rm
 
bi
rt
hs
N
 =
 8
83
 a
ut
is
m
0 
to
 1
8 
ye
ar
s
17
.6
%
 (7
28
 
m
al
es
, 1
55
 
fe
m
al
es
)
N
 =
 8
53
 w
ith
 
da
ta
, 3
4.
5%
A
ut
is
tic
 b
oy
s
Se
iz
ur
e 
di
so
rd
er
s 
w
er
e 
m
or
e 
fre
qu
en
t 
am
on
g 
au
tis
tic
 b
oy
s 
bo
rn
 p
re
te
rm
 
vs
. t
ho
se
 b
or
n 
te
rm
 (1
7.
0%
 v
s. 
8.
5%
, 
p 
= 
0.
01
); 
no
 s
uc
h 
pr
et
er
m
–t
er
m
 d
iff
er
‑
en
ce
s 
w
er
e 
fo
un
d 
in
 a
ut
is
tic
 g
irl
s
Be
n‑
Itz
ch
ak
 e
t a
l. 
[3
7]
Is
ra
el
C
ro
ss
‑s
ec
tio
na
l 
cl
in
ic
/c
om
m
un
ity
 
sa
m
pl
e
Pr
ev
al
en
ce
 ra
te
s 
an
d 
se
x 
di
ffe
r‑
en
ce
s 
in
 n
eu
ro
‑
lo
gi
ca
l p
he
no
‑
ty
pe
s, 
in
cl
ud
in
g 
ep
ile
ps
y
N
 =
 6
63
 a
ut
is
m
1 
to
 1
5 
ye
ar
s
13
.0
%
 (5
77
 
m
al
es
, 8
6 
fe
m
al
es
)
35
.0
%
**
A
ut
is
tic
 b
oy
s
N
eu
ro
lo
gi
ca
l a
no
m
al
ie
s 
w
er
e 
m
or
e 
pr
ev
al
en
t i
n 
au
tis
tic
 g
irl
s 
th
an
 in
 a
ut
is
tic
 
bo
ys
, i
nc
lu
di
ng
 m
ic
ro
ce
ph
al
y 
(1
5.
1%
 
vs
. 4
.5
%
, χ
2  =
 1
5.
0,
 d
f =
 1
, p
 <
 0
.0
01
) 
an
d 
m
in
or
 n
eu
ro
lo
gi
ca
l–
m
us
cu
lo
sk
el
‑
et
al
 d
efi
ci
ts
 (7
3.
8%
 v
s. 
57
.1
%
, χ
2  =
 8
.0
, 
df
 =
 1
, p
 <
 0
.0
01
), 
bu
t n
o 
si
gn
ifi
ca
nt
 s
ex
 
di
ffe
re
nc
es
 w
er
e 
fo
un
d 
fo
r s
ei
zu
re
s 
or
 
m
ac
ro
ce
ph
al
y
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U
SA
C
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na
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gi
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ry
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e
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ev
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 ra
te
s 
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g 
he
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 c
on
di
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ns
, 
in
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ud
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g 
ep
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ps
y
N
 =
 4
79
0 
au
tis
m
, 
N
 =
 1
,8
42
,5
75
 
ge
ne
ra
l p
op
ul
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tio
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co
nt
ro
ls
A
ll 
ag
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N
ot
 re
po
rt
ed
 fo
r 
ov
er
al
l s
am
pl
e
N
ot
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po
rt
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A
ut
is
tic
 
bo
ys
/m
en
O
ve
ra
ll 
hi
gh
er
 p
re
va
le
nc
e 
of
 e
pi
le
ps
y 
in
 
au
tis
tic
 g
irl
s/
w
om
en
 (1
8.
54
%
) t
ha
n 
in
 
au
tis
tic
 b
oy
s/
m
en
 (1
5.
14
%
, p
 <
 0
.0
5)
; 
th
is
 fi
nd
in
g 
w
as
 m
od
ul
at
ed
 b
y 
ag
e,
 
th
at
 e
pi
le
ps
y 
w
as
 fe
m
al
e‑
pr
ed
om
in
an
t 
in
 0
–1
8 
ye
ar
s 
an
d 
18
–3
5 
ye
ar
s, 
bu
t 
m
al
e‑
pr
ed
om
in
an
t i
n 
>
 3
5 
ye
ar
s 
of
 a
ge
b.
 A
ut
is
tic
 g
irl
s/
w
om
en
 c
om
pa
re
d 
to
 n
on
‑a
ut
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tic
 g
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w
om
en
In
gu
do
m
nu
ku
l e
t a
l. 
[3
8]
U
K
C
ro
ss
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infections, musculoskeletal conditions, neurologic condi-
tions) [23]. In 4790 autistic people of all ages from large 
medical registry cohorts, there was a higher prevalence of 
bowel disorders in autistic women compared to autistic 
men > 35 years of age [22]. The sixth study found a higher 
median number of medical comorbidities in autistic 
women compared to autistic men, in a community sample 
of 92 autistic adults [24].
Two studies further examined sex/gender as a predic-
tor of physical quality of life and overall health status in 
370 [25] and 255 [26] autistic adults. Female sex/gen-
der was a significant predictor of lower physical health-
related quality of life [25] and lower overall health [26]. 
Finally, two literature reviews on the physical health 
status of autistic adults regardless of sex/gender [27] and 
sex differences in developmental and medical endophe-
notypes in autism [28], respectively, reported there was 
insufficient research to reach consensus about sex/gender 
differences.
Autistic girls/women compared to  non-autistic girls/
women Three studies with population-based regis-
try samples examined the overall physical health status 
of autistic girls/women compared to non-autistic girls/
women [29–31]. Two of them compared autistic adults 
to same-sex matched controls (2040 autistic individuals 
vs. 761,409 general population individuals [29] and 1507 
autistic individuals vs. 15,070 general population controls 
Records idenfied through 
database searching
(n=2,543)
Sc
re
en
in
g
In
cl
ud
ed
El
ig
ib
ili
ty
Id
en
fi
ca
o
n
Addional records idenfied 
through other sources
(n=0)
Records aer duplicates removed
(n=1,112)
Records screened
(n=1,112)
Records excluded
(n=911)
• No primary diagnosis of 
ausm
• No sex-specific or 
gender-specific analyses
• No physical health 
condions
• Not English language
• Not peer-reviewed
• Duplicates not 
previously removedFull-text arcles assessed 
for eligibility
(n=201)
Full-text arcles excluded, 
with reasons
(n=161)
• No direct relevance to 
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conference papers, opinions 
Studies included in 
qualitave synthesis
(n=40)
Fig. 1 PRISMA flow diagram for study selection
Page 15 of 22Kassee et al. Molecular Autism           (2020) 11:84  
[30]), and the other exclusively studied autistic seniors 
(≥ 65 years of age) who were enrolled in US-based Medi-
care (4685 with autism vs. 46,850 controls [31]). All three 
studies found elevated odds for most physical health con-
ditions in autistic girls/women compared to non-autistic 
girls/women [29–31]. As a side note (also corresponding 
to the previous section), two of them also described odds 
ratios (ORs) of physical health conditions in autistic girls/
women (reference to non-autistic girls/women) in con-
trast to autistic boys/men (reference to non-autistic boys/
men) [29, 30]: Some conditions showed elevated ORs only 
in autistic girls/women, whereas others showed elevated 
ORs only in autistic boys/men (Table  2), alongside the 
majority of other conditions showing sex-similar patterns 
of elevated ORs across autistic individuals [29–31].
Theme 2: Epilepsy and Related Neurological Conditions
Eleven out of the 40 included studies specifically focused 
on, or included, epilepsy when examining sex/gender dif-
ferences in neurological conditions in autistic individuals 
[22, 30–39].
Autistic girls/women compared to autistic boys/men Five 
studies compared autistic girls/women to autistic boys/
men with respect to epilepsy [22, 32–35]. While one study 
reported no sex differences in ORs for epilepsy [32], the 
other four studies found elevated rates of epilepsy in autis-
tic girls/women compared to autistic boys/men. However, 
this finding was also associated with age, cognitive ability, 
adaptive functioning, language ability, and autism symp-
tom severity [22, 33–35]. One meta-analysis with pooled 
sample sizes of 1530 autistic children and adults from 14 
studies [33], and another study  with 6975 autistic chil-
dren from registry-based cohorts [34], found higher rates 
of epilepsy in autistic girls/women compared to autistic 
boys/men. They also found positive associations between 
rates of epilepsy and intellectual disability [33, 34], lan-
guage impairment, core autism symptoms, and motor 
dysfunction [34]. Two other registry-based studies on 
prevalence rates for comorbid health conditions, includ-
ing epilepsy, in 5815 [35] and 4790 [22] autistic individu-
als found higher prevalence of epilepsy in autistic girls/
women compared to autistic boys/men. The sex difference 
patterns were modulated by age [22, 35], cognitive ability, 
adaptive language functioning, developmental regression, 
and autism symptom severity [35].
In addition, two studies specifically explored neuro-
logical profiles including seizure disorders in autistic 
children from community-based samples [36, 37]. One 
study of 883 autistic children found seizure disorders to 
be more frequent among autistic boys born preterm vs. 
those born term, while no preterm–term differences 
were found in autistic girls [36]. The other study on 663 
autistic children found higher prevalence of neurological 
anomalies (e.g., microcephaly, minor neurological–mus-
culoskeletal deficits) in autistic girls than in autistic boys, 
but no sex differences in seizures [37].
Autistic girls/women compared to  non-autistic girls/
women Four studies reported risks of epilepsy in autis-
tic girls/women against non-autistic girls/women [30, 
31, 38, 39]. A population-based registry study of autistic 
adults found that autistic women were at significantly 
higher risks of having epilepsy than non-autistic women 
[30]. In another registry study on physical health in 
autistic seniors, epilepsy shows the largest OR among all 
conditions in autistic women compared to non-autistic 
women [31]. Similarly, two additional community-based 
studies reported elevated rates of epilepsy in autistic 
women compared to non-autistic women in a sample of 
54 autistic women and 183 non-autistic women [38] and 
in another sample of 415 autistic women and 415 non-
autistic women [39].
Theme 3: Endocrine and Reproductive Health Conditions
Ten out of the 40 included studies focused on endo-
crine and reproductive health conditions in autistic girls/
women only [40, 41] or in comparison with non-autistic 
girls/women [30, 31, 38, 39, 42–45].
Studies with  no  comparison group Two community-
based studies reported menstruation-related health chal-
lenges in autistic girls/women [40, 41]. One online sur-
vey with 124 autistic girls/women found > 90% of them 
experienced dysmenorrhea and premenstrual syndrome 
(PMS), while one-third endorsed increased autism-asso-
ciated difficulties during the menstrual cycle [40]. The 
other study on the effects of menarche on the sensory fea-
tures of autism in 53 autistic girls reported that those who 
reached menarche had lower sensory interests and mul-
tisensory processing than those who had not yet reached 
menarche [41].
Autistic girls/women compared to  non-autistic girls/
women Eight studies examined endocrine and repro-
ductive health conditions in autistic girls/women com-
pared to non-autistic girls/women [30, 31, 38, 39, 42–45]. 
A population-based registry study found that autistic 
women were at higher risks of having thyroid diseases 
than non-autistic women [30]. Another registry study 
on physical health in autistic seniors yielded similar find-
ings regarding thyroid diseases, but autistic women had 
a comparable rate of menopausal disorders compared to 
non-autistic women [31]. A community-based qualitative 
study on 123 autistic and 114 non-autistic women’s expe-
riences of menstruation found that, despite many overlap-
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ping challenges reported by both groups, autistic women 
highlighted amplification of autism-related (e.g., sensory 
and emotional regulation) challenges in sync with the 
menstrual cycle, which had significant negative impact 
on their lives [42]. Three studies focused on the preva-
lence of female-specific endocrine conditions: one from 
54 autistic women and 183 non-autistic women [38] and 
the other from 415 autistic women and 415 non-autistic 
women [39] recruited from the community, as well as 
another registry-based study on nation-wide electronic 
health records of 971 autistic women and 4855 non-autis-
tic women [43]. The findings demonstrated higher rates of 
irregular menstrual cycle [38, 39], unusually painful peri-
ods [38, 39], and polycystic ovary syndrome (PCOS) [38, 
43] in autistic women compared to non-autistic women, 
along with a range of other endocrine-related conditions 
[38, 39]. Furthermore, a nation-wide registries study of 
cancer risks with 8438 autistic children, youth, and young 
adults compared to 76,332 general population controls 
found a higher incidence of ovarian cancer in autistic 
girls/women compared to non-autistic girls/women [44]. 
Finally, a registry-based study on pregnancy outcomes in 
2198 births to 1382 autistic women of child-bearing age, 
compared to 877,742 births in 503,846 women from the 
general population, found increased risk of preeclamp-
sia, giving preterm birth, and receiving elective cesarean 
delivery for autistic women compared to non-autistic 
women [45].
Miscellaneous emerging findings
Thirteen out of the 40 studies [46–58] were in emerging 
areas of research that did not align well with the three 
major themes; they also provided relatively inconsistent 
findings. All 13 studies offered information regarding 
autistic girls/women in comparison with autistic boys/
men.
Additional neurological conditions
Three studies reported on neurological conditions 
beyond epilepsy in autism [46–48], with two examin-
ing neurological conditions as a broad category [46, 47] 
and the third, cerebral palsy [48]. One community-based 
study of 91 autistic children found that autistic girls 
had higher rates of neurological conditions than autis-
tic boys [46]. A surveillance registry-based study found 
that in 6379 8-year-old autistic children across eight US 
sites, both autistic girls and boys showed stable rates of 
change in the prevalence of neurological conditions over 
2002–2010 [47]. The final study, in a nation-wide cohort 
of 4180 autistic individuals (with ICD-10 Asperger’s syn-
drome), found increased prevalence of cerebral palsy in 
autistic individuals compared to the general population, 
without significant differences between autistic girls/
women and boys/men [48].
Obesity and overweight
Two studies focused on obesity and overweight (via body 
mass index) [49, 50]. One registry-based study including 
2976 autistic children and youth found that autistic girls 
were less likely to be obese compared to autistic boys, but 
they were equally likely to be overweight [49]. The other 
study, a community-based study of 78 autistic children, 
adolescents and adults, found that being overweight, as 
well as being obese, was more common in autistic men 
than in autistic women but with no differences found 
between autistic boys and autistic girls [50].
Gastrointestinal, metabolic, or nutritional problems
Four studies focused on gastrointestinal, metabolic, or 
nutritional conditions, comparing autistic girls/women 
and autistic boys/men [51–54]. One community-based 
study examined the prevalence of gastrointestinal prob-
lems in 169 autistic children, reporting that autistic girls 
had a greater likelihood of gastrointestinal problems than 
autistic boys and that more gastrointestinal symptoms 
were correlated with more severe core autistic symptoms 
[51]. Two were systematic reviews and meta-analyses: 
One, on peripheral iron levels and iron deficiency (1603 
autistic children pooled from 25 studies across 3 analy-
ses), found no sex/gender differences with respect to iron 
levels in autistic children [52]; the other, on mitochon-
drial dysfunction (648 autistic children and youth pooled 
from 65 studies), found a higher proportion of girls/
women in the group of those with autism plus mitochon-
drial disease compared to those with autism only [53]. 
The final study, a community-based study on vitamins A 
and D deficiencies in 332 autistic children, reported that 
autistic girls had lower serum 25-OH vitamin D than 
autistic boys [54].
Immune profile
Three studies focused on sex-specific immunological fea-
tures in autism [55–57]. Cytokine levels were measured 
in two studies of autistic children and adolescents from 
registry- and hospital-based cohorts: one with 144 (27 
cytokines measured) [55] and the other, 87 (11 cytokines 
measured) [56] autistic individuals. Both studies found 
differences in the cytokine profiles of autistic girls com-
pared to autistic boys but on different cytokines [55, 56]. 
A meta-analysis of 38 studies on 1393 autistic individu-
als regarding circulating pro-inflammatory cytokines also 
found sex/gender differences in cytokine patterns [57]. 
Altogether, these preliminary findings implicate potential 
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sex/gender differences in immune profiles related to 
autism, though with inconsistent cytokine involvement.
Autism symptoms associated with physical health
Lastly, one meta-analysis examined sex/gender dif-
ferences in 254 autistic adults regarding self-reported 
autistic characteristics, which included sensorimotor 
symptoms, some of which related to physical health, such 
as sensitivity to pain. Results revealed more severe sen-
sorimotor symptoms in autistic women than in autistic 
men [58].
Discussion
The purpose of this scoping review was to explore what 
is known about co-occurring physical health conditions 
in autistic girls/women. Out of the 201 full-text articles 
we reviewed, only 40 met our inclusion criteria, mainly 
due to the paucity of reporting on sex or gender differ-
ences among populations with autism and the low per-
centages of autistic girls/women included in the current 
literature. There is a pressing need for more research that 
includes large numbers of autistic girls/women in order 
to better understand their physical health. This should be 
prioritized in order to advance the best clinical care for 
autistic individuals [11].
Emerging patterns of co-occurring physical health con-
ditions are worth further examination and replication. 
With respect to Theme 1, the current literature suggests 
that autistic girls/women tend to have more overall phys-
ical health challenges and lower overall health and quality 
of life than do autistic boys/men [19–31]. However, apart 
from epilepsy, it is still unclear which specific conditions 
are consistently more prevalent in autistic girls/women 
compared to autistic boys/men or to non-autistic girls/
women [29–31]. Such inconsistency could be related 
to the substantial heterogeneity in the autism popula-
tion even within each sex [59] and could also be related 
to confounding factors (e.g., genetic etiological load or 
other neurodevelopmental disabilities). Based on Theme 
2, epilepsy is the most studied neurological condition in 
autism and has been relatively consistently reported to 
be more prevalent in autistic girls/women than in autis-
tic boys/men [22, 33–35]. Furthermore, these studies 
highlight heightened autism symptoms, language impair-
ment, motor dysfunction, older age, and presence of 
intellectual disability as potential confounding factors to 
epilepsy prevalence in autism [22, 33–35].
Findings in Themes 1 and 2 regarding differences 
between autistic girls/women and autistic boys/men need 
to be interpreted in light of the general pattern of case 
ascertainment in autism research so far, and the com-
plexity associated with sex/gender-related differences in 
comorbidity pattern (e.g., association with intellectual 
disability) and etiological load. With regard to ascertain-
ment bias, some have suggested that the observed asso-
ciation between autism and epilepsy is largely driven by 
co-occurring intellectual disability [60], which is in turn 
confounded by the greater proportion of autistic girls/
women with lower cognitive abilities [61] and shared 
neurobiological bases between autism and neurologi-
cal anomalies [62]. Indeed, for a long time, girls/women 
who were clinically diagnosed with autism, and hence 
included in the registry and hospital-based datasets in 
the reviewed studies, tended to be those with lower IQ, 
early-recognized and more “classic” symptoms of autism 
[63]—those who tend to carry heightened etiological 
risk factors for neurodevelopmental and physical health 
issues. Meanwhile, sex- and gender-related barriers to 
girls/women receiving an autism diagnosis [2, 4, 11] 
may result in autistic girls/women without evident intel-
lectual disability or “classic” symptoms of autism being 
under-represented in the current literature. Therefore, 
the observed differences between autistic boys/men and 
autistic girls/women in overall physical health status and 
epilepsy are likely confounded by sex- and gender-based 
ascertainment bias. It is also likely that the later recog-
nition of autism in some girls/women has resulted in 
inadequate health care [64–66], further contributing to 
poorer overall health status. However, it remains unclear 
if the same pattern of male–female differences holds in 
autistic individuals who are so far under-recognized and 
undiagnosed.
At the same time, these observed sex/gender differ-
ences could be associated with variations in etiologi-
cal load. At a group level, autistic girls/women tend to 
carry more de novo protein-truncating genetic variants 
likely causal to autism compared to autistic boys/men 
[67]. Given the pleiotropic effects of many autism-related 
genes, autistic individuals who carry these variants are 
more likely to experience other neurodevelopmental 
(e.g., intellectual disability) and physical health challenges 
(e.g., epilepsy, other neurological anomalies, cardiovas-
cular defects, obesity) [8]. This means that the observed 
sex/gender differences may further reflect, and are con-
founded by, higher co-occurrence of neurodevelopmental 
disabilities and stronger de novo genetic etiological load 
in diagnosed autistic girls/women compared to autistic 
boys/men.
Another pattern that emerged (Theme 3) was the 
greater burden of co-occurring endocrine or repro-
ductive health concerns in autistic girls/women (e.g., 
menstruation-related challenges, hormonal condi-
tions, and ovarian cancer). Nevertheless, these find-
ings should be viewed as preliminary, owing to the 
moderate sample sizes [40–42] and the reliance on 
self-report questionnaires—rather than direct clinical 
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assessments—to characterize female-specific endocrine 
conditions [38–42]. Interestingly though, this theme can 
be hypothesis generating with implications for plausible 
biological mechanisms underlying autism, endocrine 
and other associated biological alternations. Some have 
speculated that endocrine dysregulation in autistic girls/
women is partly indicative of altered prenatal sex steroid 
exposure [68, 69], which may contribute to both endo-
crine dysregulation and autism-related neurodevelop-
mental and behavioral characteristics [70–72]; see recent 
emerging empirical support [73–77]. How such prenatal 
endocrine factors contribute to the mechanisms lead-
ing to autism and sex differences in concurrent physical 
health disorders remains unclear and is an area requiring 
more in-depth mechanistic investigation. There is grow-
ing evidence supporting the role of multidirectional inter-
actions between hormonal regulation, prenatal immune 
activation, epigenetic regulation in key brain regions, and 
postnatal environments in producing a range of distinct 
but related autistic phenotypes [78–80]. It is possible 
that there are shared mechanisms underlying autism and 
co-occurring endocrine and immune alterations, with sex 
differential mechanisms involved.
Finally, there is increasing evidence that gastrointes-
tinal [81] and metabolic/nutritional conditions [82], 
including obesity and diabetes [83], have a high fre-
quency of co-occurrence in autistic individuals. These 
conditions could involve shared etiological mechanisms 
with autism as well as with life experiences (e.g., lifestyle, 
health care support, medication use) of autistic people. 
The emerging but preliminary findings regarding sex/
gender differences in these domains suggest that they 
may be especially important to the physical health of 
autistic girls/women. Elucidating associated sex/gender-
related mechanisms requires more in-depth research.
Clinical Implications (also see Fig. 2)
The finding that autistic girls/women experience more 
overall physical health challenges than non-autistic girls/
women and autistic boys/men is of immediate clini-
cal relevance. Improving physical health is integral to 
the care of all autistic individuals [84, 85]. Frontline and 
Fig. 2 Exemplary findings and clinical implications. Prevalence rates of exemplary physical health conditions were taken from the largest sample 
size studies included in this review (i.e., [43] for polycystic ovary syndrome [PCOS] and [35] for epilepsy) and a representative study in the general 
population (i.e., for epilepsy [93])
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primary care clinicians should regularly monitor and 
address health care needs for autistic children, youth, 
and adults alike [86, 87], especially for female individu-
als [88]. For autistic girls/women, this scoping review 
provides indication for clinicians to particularly attend to 
the risks of epilepsy, endocrine and reproductive health 
issues, as well as other neurological, gastrointestinal, 
metabolic, nutritional, and immune conditions, among 
various physical health issues. To achieve holistic sup-
port, developing a women’s health lens when providing 
clinical care to autistic girls/women is essential and will 
significantly enrich sex- and gender-informed health care 
for all autistic people. Sex- and gender-informed health 
promotion strategies need to be applied across the life 
span. Conversely, improved attention to physical health 
in girls/women who also experience difficulties in social 
communication, restricted/stereotyped behaviors and 
sensory issues might also facilitate the identification of 
later recognized autism in girls/women [89].
Another key consideration is the interplay between 
physical and mental health. Autistic people are prone 
to experiencing mental health challenges (which we 
did not review here) [15]. However, many psychiatric 
medications for such challenges have side effects that 
are more commonly experienced in autistic compared 
to non-autistic individuals [84, 90, 91], contributing 
to heightened risk to physical health (e.g., weight gain 
and endocrine problems related to psychotropic medi-
cations). These findings have not yet been sufficiently 
studied in a sex-/gender-specific manner. Meanwhile, 
physical health challenges (e.g., epilepsy, hormonal dys-
regulation) can have detrimental impacts on mental 
health and affect mood and behavior. Such complexity 
and interplay may result in the high clinical needs and 
multiple service use that are common in the autism pop-
ulation, particularly among girls/women [64–66]. Many 
of these  specific physical health challenges are treatable 
with the proviso that clinical trials need to disaggregate 
their data by sex and gender, which is unfortunately still 
insufficiently done for trials involving autistic people.
Timely diagnosis and treatment will enhance well-
being associated with both physical and mental health of 
autistic individuals across the life span. This review has 
revealed that autistic girls/women are a population with 
unique health needs. Therefore, it requires us to develop 
comprehensive services that integrate developmental, 
mental, and physical health for autistic girls/women.
Limitations
There are several limitations to consider in interpreting 
our findings. First, it is possible that we were unable to 
identify all studies relevant to our guiding questions due 
to the heterogeneity in how physical health conditions 
were assessed and reported in the literature. Neverthe-
less, based on the principles of a scoping review, we have 
identified potential areas in the literature that warrant 
future investigation and areas with insufficient informa-
tion as yet to make firm conclusions. Second, the deci-
sion to focus on physical health, thus excluding studies 
only focusing on psychiatric co-occurring conditions, 
meant that we could not explore how mental health and 
physical health are intertwined in autistic people, par-
ticularly in girls/women. Finally, our scoping review dem-
onstrates that understandings of the physical health of 
autistic girls/women are still emerging. The limited num-
ber of studies in each theme, and their varying quality 
and research methodologies, makes it difficult to reach 
definitive conclusions.
However, several lessons about significant gaps in 
the clinical and research literature about autism can 
be learned from our review to inform future research 
directions. There is a lack of consistent, basic epidemio-
logical information on the prevalence and incidence for 
co-occurring physical health conditions in the autism 
population by sex and, in particular, by gender. Reliable 
and valid measurement tools for physical health in autis-
tic individuals need to be further developed. Addition-
ally, there are insufficient longitudinal studies to chart 
the emergence of co-occurring conditions and rand-
omized control trials to assess treatment for these condi-
tions. There are also insufficient biological studies on the 
mechanisms of the development of physical health chal-
lenges in autism by sex and by gender. Further, there is 
significant underrepresentation of autistic girls/women 
in most studies, and only a small minority of studies are 
equipped to or have formally examined and reported 
sex/gender differences in their primary analyses. These 
highlight the ignorance about how sex and gender influ-
ence autism, perhaps due to a male-biased lens. The rela-
tive lack of awareness about women’s health and female 
experiences in the scientific and clinical knowledge about 
physical health and autism leaves girls/women diagnosed 
with autism at distinct disadvantages. Targeted research 
on autistic girls/women is clearly needed. Future stud-
ies on autism should be designed to achieve sex/gender 
equity by ensuring a male/female ratio closer to the gen-
eral population rate (i.e., ~ 3:1) [4]. For research focusing 
on delineating sex-related or gender-related effects, bal-
anced inclusion of participants with diverse sexes and 
genders should be targeted [2, 92]. Finally, it is extremely 
rare in the current empirical literature that sex (biologi-
cal attributes) and gender (psychological, social, and 
cultural attributes) are defined and examined separately 
and in valid ways. These gaps need to be addressed in 
future research, alongside a clarification of sources of 
demographic, clinical, and etiological heterogeneity 
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such as age, pubertal stage, developmental trajectories, 
intellectual functioning, and genetic background. Such 
clarification is fundamental for future studies to gener-
ate etiological and mechanistic insights by studying co-
occurring physical health conditions in autism using 
sex- and gender-informed frameworks.
Conclusions
To our knowledge, this is the first scoping review on 
physical health in autistic girls/women. Emerging themes 
suggest that autistic girls/women tend to have heightened 
rates of a variety of co-occurring physical health chal-
lenges compared to autistic boys/men and non-autistic 
girls/women. Clinicians should provide holistic care that 
integrates not only developmental and mental health, 
but also physical health. Future studies need to include 
sufficient numbers of autistic girls/women to achieve 
adequate power, attend to physical health and the inter-
twined nature of developmental, mental, and physical 
health, and use sex- and gender-informed lenses.
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